Case Studies

Market access strategy / Systematic literature review / Cost-effective model / Value proposition / Global reimbursement dossier / Objection handler / Pharma

Delivering on global market access strategy, evidence generation and communication objectives

Our client’s global market access team were looking for a consultancy who could support them from strategy to implementation. As the client was in the early stages of developing a new product, they first wanted to understand the challenges and opportunities that their new treatment would face when launching in different markets. Subsequently, the client wanted support with evidence generation and the development of their value communication materials.

US market access strategy / Market research / Digital health technology / Medtech

Exploring the US market landscape and developing strategy for a digital health technology

Our client was looking to explore the routes to reimbursement in the US for their product in early stages of development. The product consisted of an already Food and Drug Administration (FDA) approved class I medical device and a new cloud-based mobile app. The client was looking to understand the conventional route to reimbursement for the combined product, as well as other applicable reimbursement and patient access schemes (PASs), including the evidence requirements and formal mechanisms for application and review.

US market access strategy / Health economics / AMCP dossier / Budget impact model / Local market adaptation / Pharma

Building a budget impact model for AMCP submission in the US

Our client was launching a new treatment in the US. They were looking for a health economics consultancy with knowledge of the US market to develop a budget impact model that would resonate with US payers and generate data suitable for Academy of Managed Care Pharmacy (AMCP) formulary submission.

Reimbursement strategy / Funding strategy / Product launch / Evidence strategy / Stakeholder mapping / Digital health technology

Exploring funding and reimbursement routes for digital health technologies across EU4, UK and US

Our client had several innovative digital health solutions in their pipeline and was looking to understand how to obtain funding in major European and US markets. The client was keen to explore both conventional reimbursement routes for digital health technologies across these markets, as well as any alternative patient access, funding, evidence development and early access schemes available.

Market access strategy / Evidence strategy / Pricing strategy / HTA payer insights / Pharma

Gaining global payer insights to inform clinical trial design, price and market access strategy

Our client had a biologic product in clinical development for several different dermatological conditions. In preparation for their Phase 3 trial for the second planned indication, they sought input from payers into key elements of the target product profile (TPP).

Market access strategy / Evidence strategy / Market research / Targeted literature review / Rare disease / Orphan drugs / Pharma

Researching market access pathways, reimbursement requirements and implications of orphan drug designation for a rare disease product

With a rare disease therapy in early development, our client wanted to gain a deeper understanding of the market access routes available and the evidence requirements for key reimbursement pathways.

Value communication / Budget impact model / Value proposition / Digital toolkit / NHS insights / iPad App / CRM integration / KAM training / Pharma

Developing a digital toolkit to demonstrate the value of a pharmaceutical technology to secondary care providers

Our client was looking to develop a digital value communication tool for their Key Account Managers (KAMs) to use with secondary care decision-makers to demonstrate the clinical and economic value of bringing prescribing practices in line with new NICE treatment guidelines that included a recommendation for use of their product.

The client was looking to help a newly formed team to improve their understanding of how value is perceived across the NHS by different key stakeholders. Their overall aim was to understand how the team could deliver value for the NHS in new ways whilst better supporting clinicians in the implementation of clinical guidelines.

European payer insights / Market access strategy / Advisory board / Pricing strategy / Pharma

Gaining European payer insights with an advisory board

Our Client was now looking to gain European payer insights for potential future indications across the cardiovascular disease space. Our Client wanted to understand the challenges and opportunities that their new treatment would face when launching in different markets.

Value communication / Cost-consequence model / Health economics / Digital toolkit / iPad App / Local market adaptation

Optimising visualisation and communication in an app-based Cost-Consequence Model

Our client had a cost-consequence model in Excel that had been developed by their internal global market access team. They were seeking an agency to re-build this model as an interactive digital app for use in the field.

Value communication / Data visualisation dashboard / Real-world data / Connected Insights / Veeva-compatible

Using real-world data to build a case for change

Our client was looking for a visually compelling way to enable their field teams to present health data on relevant health economies to NHS decision-makers.

Health policy / Pharma/ Medical devices / Above brand/ Europe/ Targeted literature review/ Expert opinion/ Evidence submission

Challenging European policy proposals with an evidence-driven submission on behalf of a cross-industry consortium

We were approached by a consortium of global pharmaceutical and medical device companies who were concerned about proposed new European legislation that would impact the group’s products and detrimentally impact patient care.

Global value dossier (GVD) / Value proposition / Systematic literature review / Global evidence / Data analysis / Digital GVD Platform / Medical device

Communicating value with a suite of visually impactful materials connected via a digital platform

To support payer engagement and reimbursement activities, our client was looking for a partner to develop a suite of value communication materials for their medical device.

Systematic literature review / Network meta-analysis / Cost calculator / Pharma / Clinical evidence / Economic evidence / Real-world evidence / Manuscript

Synthesising gold standard clinical and economic evidence for each step of the reimbursement and market access journey

Our top 20 Pharma client was looking to build a gold standard evidence base to support their global regulatory and reimbursement strategy for the launch of a key oncology product. We were initially approached to run an early clinical systematic literature review. This has developed into a multi-year programme of work, covering real-world evidence, clinical, and economic reviews.

Market access strategy/ Pricing / Market research / Payer insights / Price-volume decision-making tool / Pharma / Europe

Modelling pricing and market dynamics in a competitive therapeutic landscape across the EU4 and UK markets

Our client wished to understand how pricing and market dynamics were impacting the uptake of their product in France, Germany, Italy, Spain, and the UK. Operating in a highly competitive disease area, the client was looking for insights into key factors that could influence uptake.

Market access strategy / Pricing / Market research / Payer insights / UK private healthcare / Pharma / Product launch

Conducting market research into the UK private healthcare market to inform market access and pricing strategy

Our Global Pharma client wanted to gain a deeper understanding of the UK private healthcare market ahead of their product launch. We proposed conducting research into the logistics of the private market, pricing structures, how services are organised, and how consumer demand is estimated to determine their go-to market strategy.

Market access strategy / Value proposition / Competitor mindset / Objection handling / Mock payer meeting / Team workshop / Pharma

Reinvigorating value messaging in preparation for the launch of a competitor product – A Competitor Mindset Workshop

Our global client was preparing for the upcoming launch of a direct competitor and needed to prepare local market access teams to mitigate for the threats that this posed. After designing and delivering negotiation skills training for the client’s local market access teams, we then recommended hosting a competitor mindset challenge at their annual market access team conference.

Value proposition / Evidence strategy / Systematic literature review / Global market access / Brochures / USA / Medical devices

Communicating value to healthcare customers in key markets: A global value story and US-market specific brochures

Our client was looking to communicate the value offered by their specialist Class I medical device to healthcare customers in key global markets. The client was seeking a partner to create a flexible resource that would provide their sales associates with the evidence base and value messaging to engage a predominantly clinical audience. We were later asked to provide supporting brochures for US sales teams to use as educational and marketing pieces with clinicians.

Rapid review / Research strategy / Evidence strategy / HEOR / Real-world evidence / USA / Pharma

Evaluating existing research and identifying evidence gaps to inform future research priorities

Our client’s US HEOR team sought support to assess the volume and quality of existing research for a series of predefined questions to identify evidence gaps. They aimed to bring a more evidence-based approach to prioritising their annual research investments.